Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2722-2732
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2722
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2722
Table 2 Descriptive epidemiology of Alaska Native gastric cancer patients n (%)
Overall | Female | Male | |
Patients | 132 | 50 (37.9) | 82 (62.1) |
Mean age (yr) | 59.8 ± 1.2 | 62.4 ± 2.0 | 58.2 ± 1.4 |
Histological type | |||
Diffuse | 75 (56.8) | 29 (58.0) | 46 (56.1) |
Intestinal | 51 (38.6) | 16 (32.0) | 35 (42.7) |
NOS | 6 (4.5) | 5 (10.0) | 1 (1.2) |
Blood type | |||
A+ | 55 (41.7) | 23 (46.0) | 32 (39.0) |
AB+ | 8 (6.1) | 3 (6.0) | 5 (6.1) |
B+ | 9 (6.8) | 5 (10.0) | 4 (4.9) |
O+ | 30 (22.7) | 10 (20.0) | 20 (24.4) |
Unknown | 30 (22.7) | 9 (18.0) | 21 (25.6) |
Histological appearance | |||
Signet Ring | 52 (39.4) | 23 (46.0) | 29 (35.4) |
Adenocarcinoma | 80 (59.8) | 27 (54.0) | 53 (64.6) |
Linitis Plastica, AC | 2 (2.5) | 0 (0) | 2 (3.8) |
Mucinous, AC | 2 (2.5) | 0 (0) | 2 (3.8) |
Tubular, AC | 1 (1.3) | 0 (0) | 1 (1.9) |
Papillary | 1 (1.3) | 0 (0) | 1 (1.9) |
NOS, AC | 75 (93.8) | 27 (100) | 46 (86.8) |
Stage | |||
I | 28 (21.2) | 8 (16.0) | 20 (24.4) |
II | 24 (18.2) | 6 (12.0) | 18 (22.0) |
III | 14 (11.4) | 4 (8.0) | 10 (12.2) |
IV | 66 (50.0) | 32 (64.0) | 34 (41.5) |
Grade | |||
Well/moderately differentiated | 35 (26.5) | 9 (18.0) | 26 (31.7) |
Poorly differentiated | 88 (66.7) | 36 (72.0) | 52 (63.4) |
Unknown | 9 (6.8) | 5 (10.0) | 4 (4.9) |
Anatomic site | |||
GE JX | 12 (9.1) | 5 (10.0) | 7 (8.5) |
Cardia | 10 (7.6) | 5 (10.0) | 5 (6.1) |
Fundus | 12 (9.1) | 6 (12.0) | 6 (7.3) |
Body | 33 (25.0) | 10 (20.0) | 23 (28.0) |
Antrum | 18(13.6) | 8 (16.0) | 10 (12.2) |
Pylorus | 17 (12.9) | 7 (14.0) | 10 (12.2) |
Overlap (multifocal) | 27 (20.5) | 9 (18.0) | 18 (22.0) |
Unspecified | 3 (2.3) | 0 (0) | 3 (3.7) |
Regions of Alaska | |||
North | 38 (28.8) | 17 (34.0) | 21 (25.6) |
Interior | 11 (8.3) | 1 (2.0) | 10 (12.2) |
Southwest | 40 (30.3) | 15 (30.0) | 25 (30.5) |
Southcentral | 40 (30.3) | 17 (34.0) | 23 (28.0) |
Southeast | 3 (2.3) | 0 (0) | 3 (3.7) |
Treatment2 | |||
Chemotherapy only | 40 (30.3) | 12 (24.0) | 28 (34.1) |
Neoadjuvant | 21 (15.9) | 8 (16.0) | 13 (15.9) |
Adjuvant | 12 (9.1) | 4 (8.0) | 8 (9.8) |
Resection only | 12 (9.1) | 5 (10.0) | 7 (8.5) |
Neoadjuvant, resection, adjuvant | 9 (6.8) | 3 (6.0) | 6 (7.3) |
None | 38 (28.8) | 18 (36.0) | 20 (24.4) |
Metastasis site1 | |||
Omentum/peritoneium/diaphram | 27 (41.5) | 14 (43.8) | 13 (38.2) |
Liver | 14 (21.5) | 6 (18.8) | 8 (23.5) |
Lung | 1 (1.5) | 0 (0) | 1 (2.9) |
Bone | 2 (3.1) | 0 (0) | 2 (5.9) |
Ovary | 6 (9.2) | 6 (18.8) | 0 (0) |
Multiple Sites | 15 (23.1) | 6 (18.8) | 10 (29.4) |
Additional clinical and pathological variables | |||
H. pylori | 52 (41.3) | 20 (41.7) | 32 (41.0) |
Chronic gastritis | 101 (76.5) | 38 (76.0) | 63 (76.8) |
GERD | 51 (39.5) | 18 (36.0) | 33 (41.3) |
Gastric ulcer | 91 (68.9) | 35 (70.0) | 56 (68.3) |
Tobacco | 108 (81.8) | 36 (72.0) | 72 (87.8) |
Family history GI cancer | 38 (28.8) | 16 (32.0) | 21 (25.6) |
- Citation: Martinson HA, Shelby NJ, Alberts SR, Olnes MJ. Gastric cancer in Alaska Native people: A cancer health disparity. World J Gastroenterol 2018; 24(25): 2722-2732
- URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2722.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i25.2722